Format

Send to

Choose Destination
Neuromodulation. 2013 Jul-Aug;16(4):370-5. doi: 10.1111/ner.12032. Epub 2013 Feb 21.

Novel spinal cord stimulation parameters in patients with predominant back pain.

Author information

1
Dwight D. Eisenhower Army Medical Center, Ft. Gordon, GA, USA.

Abstract

OBJECTIVES:

To examine the feasibility of novel high-frequency spinal cord stimulation therapy in a cohort of patients with chronic predominant back pain during a four day, percutaneous trial.

DESIGN:

Prospective, multicenter open label pilot trial.

SETTING AND PATIENTS:

 Twenty-four patients with back pain greater than leg pain who were candidates for spinal cord stimulation were trialed at five U.S. centers.

INTERVENTIONS:

Patients completed a percutaneous trial with a commercially available spinal cord stimulator. The implanted leads were then connected to the novel external stimulation device and patients were trialed for an additional four days.

OUTCOME MEASURES:

Pain intensity ratings, subjective descriptions, and patients' preference.

RESULTS:

There was significant improvement from baseline in overall pain scores (8.68 to 2.03, [p < 0.001]) and back pain scores (8.12 to 1.88, [p < 0.001]) with the investigational stimulation. The investigational stimulation was preferred to the commercially available systems in 21 of 24 patients (88%).

CONCLUSIONS:

Patients with predominant back pain reported a substantial reduction in overall pain and back pain when trialed with high-frequency spinal cord stimulation therapy.

KEYWORDS:

Axial back pain; failed back surgery syndrome; high frequency; low back pain; neuromodulation; neurostimulation; spinal cord stimulation

PMID:
23433237
DOI:
10.1111/ner.12032
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center